Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eeles

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
Oncogene|October 9, 2007
Complex patterns of ETS gene alteration arise during cancer development in the human prostateJ Clark, G Attard, S Jhavar, et al.
Oncogene|October 18, 2006
Diversity of TMPRSS2-ERG fusion transcripts in the human prostateJ Clark, S Merson, S Jhavar, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|November 13, 2008
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancerJ F Knight, C J Shepherd, S Rizzo, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2010
Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation studyT Guerrero Urbano, V Khoo, J Staffurth, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
Journal of Medical Genetics|April 17, 2008
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinicsA C Antoniou, R Hardy, L Walker, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|May 29, 2008
Diagnostic radiation procedures and risk of prostate cancerP Myles, S Evans, A Lophatananon, et al.
Oncogene|October 9, 2007
Complex patterns of ETS gene alteration arise during cancer development in the human prostateJ Clark, G Attard, S Jhavar, et al.
Oncogene|October 18, 2006
Diversity of TMPRSS2-ERG fusion transcripts in the human prostateJ Clark, S Merson, S Jhavar, et al.
British Journal of Cancer|April 21, 2012
Germline BRCA1 mutations increase prostate cancer riskD Leongamornlert, N Mahmud, M Tymrakiewicz, et al.
British Journal of Cancer|November 13, 2008
TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancerJ F Knight, C J Shepherd, S Rizzo, et al.
British Journal of Cancer|September 29, 2011
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patientsZ Kote-Jarai, D Leongamornlert, E Saunders, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2010
Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation studyT Guerrero Urbano, V Khoo, J Staffurth, et al.
British Journal of Cancer|December 10, 2009
Mutation analysis of the MSMB gene in familial prostate cancerZ Kote-Jarai, D Leongamornlert, M Tymrakiewicz, et al.
British Journal of Cancer|February 22, 2014
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced diseaseD Leongamornlert, E Saunders, T Dadaev, et al.
Journal of Medical Genetics|April 17, 2008
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinicsA C Antoniou, R Hardy, L Walker, et al.
Pageof 11